Concepedia

Carmen Burkhardt

CB

Statistics

Publications

6

Citations

575

H-Index

6

Active since

2001

Affiliations

Affimed Therapeutics (Germany)(Current)

Carmen Burkhardt is an author at Affimed Therapeutics (Germany) specializing in life sciences, enzyme inhibition, and oncology.

Publications per year

2001–2014

6

Publications

6

Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group

Thomas Beckers, Carmen Burkhardt, H. Wieland et al. · International Journal of Cancer · 2007 · 194 citations · Full text

Medicine, Oncology, Pharmacology +8

A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30<sup>+</sup>tumor cells

Uwe Reusch, Carmen Burkhardt, Ivica Fucek et al. · mAbs · 2014 · 159 citations · Full text

Life Sciences, Immunology, Oncology +17

Effective Dephosphorylation of Src Substrates by SHP-1

Carsten Frank, Carmen Burkhardt, Diana Imhof et al. · Journal of Biological Chemistry · 2004 · 108 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Nuclear DNA Helicase II/RNA Helicase A Binds to Filamentous Actin

Suisheng Zhang, Katrin Buder, Carmen Burkhardt et al. · Journal of Biological Chemistry · 2002 · 47 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +10

Trithiocarbonates as a Novel Class of HDAC Inhibitors: SAR Studies, Isoenzyme Selectivity, and Pharmacological Profiles

Florian Dehmel, Steffen Weinbrenner, Heiko Julius et al. · Journal of Medicinal Chemistry · 2008 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

1–5 of 6